| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |